Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICTRA adalimumab tapering in rheumatoid arthritis remission
2014-001114-26Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by AbbVie Inc. Primary endpoint: Association between baseline MRI inflammation and flare. Started Aug 2014; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2014-001114-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001114-26.